<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Pharma BI &#187; BI Solutions</title>
	<atom:link href="http://pharma-bi.com/category/bi-solutions/feed/" rel="self" type="application/rss+xml" />
	<link>http://pharma-bi.com</link>
	<description>Business Intelligence Blog</description>
	<lastBuildDate>Thu, 04 Feb 2010 21:29:06 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.6</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Understanding Customer Feedback: How Visualizations Quickly Guide Us to Useful Conclusions</title>
		<link>http://pharma-bi.com/2009/11/understanding-customer-feedback-how-visualizations-quickly-guide-us-to-useful-conclusions/</link>
		<comments>http://pharma-bi.com/2009/11/understanding-customer-feedback-how-visualizations-quickly-guide-us-to-useful-conclusions/#comments</comments>
		<pubDate>Fri, 06 Nov 2009 23:43:10 +0000</pubDate>
		<dc:creator>Christine Muser</dc:creator>
				<category><![CDATA[Analytics]]></category>
		<category><![CDATA[Marketing]]></category>
		<category><![CDATA[Visualization]]></category>

		<guid isPermaLink="false">http://pharma-bi.com/?p=461</guid>
		<description><![CDATA[<p>Have you ever had the “pleasure” of slogging through hundreds of feedback forms from a seminar or conference?  Have you ever noticed how the mind seems to dwell on the negative comments, maybe even to the point that all the positives seem to loose their luster?  That’s when crunching actual survey numbers can help put [...]]]></description>
			<content:encoded><![CDATA[<p>Have you ever had the “pleasure” of slogging through hundreds of feedback forms from a seminar or conference?  Have you ever noticed how the mind seems to dwell on the negative comments, maybe even to the point that all the positives seem to loose their luster?  That’s when crunching actual survey numbers can help put things into perspective: either there really were problems or we are about to fall prey to the naysayers and constant critics.</p>
<p>For example, this heat map makes it obvious that Session C was the least popular event in this conference – but notice also that the range of scores is fairly close together.  In this example, attendees used a 5 point scale, with 1 being the least favorable score and 5 being the most favorable score.   Seeing that the lowest average score was above 4 tells us that, overall, attendees were quite happy with this conference.</p>
<p style="text-align: center;">
<div id="attachment_462" class="wp-caption aligncenter" style="width: 310px"><a href="http://pharma-bi.com/wp-content/uploads/2009/11/Session_Evaluations.jpg"><img class="size-medium wp-image-462" title="Heatmap: Session Evaluations" src="http://pharma-bi.com/wp-content/uploads/2009/11/Session_Evaluations-300x137.jpg" alt="A heatmap showing how each individual session was rated along multiple criteria -- click on the picture to enlarge it" width="300" height="137" /></a><p class="wp-caption-text">A heatmap showing how each individual session was rated along multiple criteria -- click on the picture to enlarge it</p></div>
<p>Of course we also want to understand what worked well and what didn’t work so well.  Let us take a more detailed look at Session C.</p>
<div id="attachment_465" class="wp-caption aligncenter" style="width: 310px"><a href="http://pharma-bi.com/wp-content/uploads/2009/11/Session_C_Scores.jpg"><img class="size-medium wp-image-465" title="Individual Scores for Session C" src="http://pharma-bi.com/wp-content/uploads/2009/11/Session_C_Scores-300x189.jpg" alt="Click the picture to enlarge it" width="300" height="189" /></a><p class="wp-caption-text">Click the picture to enlarge it</p></div>
<p>Very quickly we can tell that the audience was critical of the session content and how it was presented rather than the speaker’s knowledge about the subject.  More than 90% felt that the speaker had an adequate background to present on this topic.  But less than 75% were happy with the way the information was presented and how it related to their job. A few people awarded low scores of 2 and 1, but it is encouraging that these low scores came from fewer than 10% of the audience members.</p>
<p>Just to provide a contrast, let’s also take a look at Session B, clearly the favorite of this event.</p>
<div id="attachment_467" class="wp-caption aligncenter" style="width: 310px"><a href="http://pharma-bi.com/wp-content/uploads/2009/11/Session_B_Scores.jpg"><img class="size-medium wp-image-467" title="Session B Scores" src="http://pharma-bi.com/wp-content/uploads/2009/11/Session_B_Scores-300x187.jpg" alt="Individual Scores for Session B" width="300" height="187" /></a><p class="wp-caption-text">Individual Scores for Session B</p></div>
<p>There is no doubt that the audience rated this Session very highly across the board: 74% or more audience members awarded it the highest score across all measures.  Notice that this session, too, received a handful of low scores.</p>
<p>As we can see here, sometimes we only need a few pictures to gain useful insights.   No doubt, if this were a more involved customer survey, we would need more and very likely different graphs to discern the finer points of attitudes and perceptions &#8212; especially when such information is tracked over time.  But pictures like these are a good start to find out where to focus such additional efforts.</p>
]]></content:encoded>
			<wfw:commentRss>http://pharma-bi.com/2009/11/understanding-customer-feedback-how-visualizations-quickly-guide-us-to-useful-conclusions/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Data Modeling: Patient Centric vs. Unit Centric</title>
		<link>http://pharma-bi.com/2009/05/data-modeling-patient-centric-vs-unit-centric/</link>
		<comments>http://pharma-bi.com/2009/05/data-modeling-patient-centric-vs-unit-centric/#comments</comments>
		<pubDate>Thu, 07 May 2009 20:20:16 +0000</pubDate>
		<dc:creator>Christine Muser</dc:creator>
				<category><![CDATA[BI Solutions]]></category>
		<category><![CDATA[Marketing]]></category>

		<guid isPermaLink="false">http://pharma-bi.com/?p=296</guid>
		<description><![CDATA[<p>Sometimes counting pills just isn&#8217;t enough.  When developing forecasts or trying to track product performance one has to consider how a drug is being used and look beyond the mere number of pills or vials on the market.</p>
<p>A good starting point includes looking at standard courses of therapy, average daily dose and similar proxies.   A [...]]]></description>
			<content:encoded><![CDATA[<p>Sometimes counting pills just isn&#8217;t enough.  When developing forecasts or trying to track product performance one has to consider how a drug is being used and look beyond the mere number of pills or vials on the market.</p>
<p>A good starting point includes looking at standard courses of therapy, average daily dose and similar proxies.   A better approach also considers factors such as treatment location, actual patient usage data, insurance coverage, and insights derived through primary research.   Each of these attributes takes real patients into consideration and thus can provide a better sense of what is happening in the market place.</p>
<p>These are some instances when patient centric modeling makes sense:</p>
<ul type="disc">
<li>A      mature market with generics and significant off label use</li>
<li>When products      are approved for multiple indications but we are only interested in a      sub-set of these indications</li>
<li>We are      trying to assess market potential for a new product or indication without the benefit of      a direct competitor</li>
</ul>
<p>Here is an <a href="../../../../../2009/02/21/multiple-indication-muddle/">example of how a patient centric data model</a> may be developed and why a unit centric approach (i.e. &#8220;counting pills&#8221;) does not always work.</p>
<p>Modeling data around patients involves more work than just counting pills. One has to identify data sources that provide relevant insights and one has to determine where the blind spots in that data are.  Since no data is perfect, one also has to figure out how to work around these blind spots.</p>
<p>Not only does such a model have to be developed, it also has to be maintained.  The market evolves over time, and today&#8217;s assumptions will no longer work at some point in the future.  To maintain a model requires regular updates and reviews of the underlying data and assumptions.  It also requires frequent &#8220;gut checks&#8221; against other market intelligence and an understanding of market influences.</p>
<p><strong>Bottom line: </strong>patient centric modeling may not always be cost effective or appropriate, but when multiple indications and uses muddy the playing field it really clears things up when we can consider how products are actually being used.</p>
]]></content:encoded>
			<wfw:commentRss>http://pharma-bi.com/2009/05/data-modeling-patient-centric-vs-unit-centric/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Looking Ahead: More Data, More Details &#8211; Less Work?</title>
		<link>http://pharma-bi.com/2009/03/looking-ahead-more-data-more-details-less-work/</link>
		<comments>http://pharma-bi.com/2009/03/looking-ahead-more-data-more-details-less-work/#comments</comments>
		<pubDate>Sat, 07 Mar 2009 03:12:48 +0000</pubDate>
		<dc:creator>Christine Muser</dc:creator>
				<category><![CDATA[BI Solutions]]></category>
		<category><![CDATA[Marketing]]></category>
		<category><![CDATA[Sales]]></category>

		<guid isPermaLink="false">http://pharma-bi.com/?p=238</guid>
		<description><![CDATA[<p>As companies grow, so do the demands on their Sales Operations and Marketing Research teams.  As new products are launched and sales forces grow, BI managers need to answer ever more questions from ever more people about ever more data and ever more details.  The &#8220;working smarter&#8221; solution to deal with this increasing demand usually [...]]]></description>
			<content:encoded><![CDATA[<p>As companies grow, so do the demands on their Sales Operations and Marketing Research teams.  As new products are launched and sales forces grow, BI managers need to answer ever more questions from ever more people about ever more data and ever more details.  The &#8220;working smarter&#8221; solution to deal with this increasing demand usually involves new skills or new technology or additional resources &#8211; and the time and resources needed to implement them.</p>
<p>Working smarter can be accomplished by</p>
<ul type="disc">
<li>Streamlining      processes</li>
<li>Automating      routine tasks</li>
<li>Reducing      errors</li>
<li>Letting      go of less important tasks</li>
<li>Finding      someone with the right skills to do the job.</li>
</ul>
<p>In this article we will take a look at how to meet increasing demands without simply doing more work.</p>
<p><strong>Streamlining Processes</strong></p>
<p>Most of us easily recognize this scenario: a BI manager is asked to provide a &#8220;quick analysis&#8221; to answer a burning business question.  Sometime later the manager is asked to update the results of this &#8220;quick analysis&#8221; and before you know it the one-time &#8220;quick analysis&#8221; turns into a regular report.</p>
<p>Chances are good that the manager initially did not worry too much about how efficiently the analysis was done, as long as the results could be delivered quickly.  Chances are equally good, that the process for performing this &#8220;quick analysis&#8221; can be streamlined to consume less time and resources.</p>
<p>Some ways in which we can streamline processes include:</p>
<ul type="disc">
<li>Having      data in a more useful format</li>
<li>Pre-calculating      certain results and storing them where they can be easily retrieved</li>
<li>Employing      technologies like dashboards and pivot tables to quickly retrieve      different views of the data.</li>
</ul>
<p>If the requested analysis requires significant effort, one should also review the entire process from data collection to processing to producing output.  Chances are good that some tasks in that process can be done more efficiently or that by reorganizing the process itself we can save time and effort.  If certain tasks have to be repeated over and over again they become a candidate for automation.</p>
<p><strong>Automating Routine Tasks</strong></p>
<p>Our article about comparing a product against competitors with <a href="../../../../../2009/02/21/multiple-indication-mania/">multiple indications</a> provides an excellent case study for automating routine tasks.  In that scenario, product units have to be converted into more useful information, taking into account how and where products are used.  To account for all this, raw units have to be factored each time new unit data becomes available &#8211; a tedious task which is also prone to human error.</p>
<p>Unlike humans, computers excel at processing routine and tedious tasks, so why not give them that job?</p>
<p><strong>Reducing Errors</strong></p>
<p>The more critical the information, the more questions will be asked.  This axiom lies at the root of many BI headaches and its impact snowballs when errors occur.  Each error we find chips away at the level of trust we have in the information.  As BI managers we need to provide the most accurate information we can, given the resources at our disposal.</p>
<p>Automation represents one way in which to reduce errors, but we can do more.  Spot checking, quality control steps like tying out sub-totals and checking whether the results &#8220;make sense&#8221; should be an integral part of every information delivery.  Even better, we usually can automate some of these QC steps.</p>
<p><strong>Letting go of less important tasks</strong></p>
<p>The article &#8220;<a href="../../../../../2009/03/03/making-time-for-the-future/">Making Time For The Future</a>&#8221; addresses this topic in more detail.  Suffice it to say here that letting go of less important tasks allows us to spend more time on the more important ones.</p>
<p><strong>Finding someone with the right skills to do the job.</strong></p>
<p>This brings us to the last item on this list: to get all of this done, we sometimes have to look for someone else to do the job &#8211; either because we do not have the time or the necessary skills.  This raises questions like:</p>
<ul type="disc">
<li>Can we      afford additional headcount or a consultant?</li>
<li>Is      this a long term need or a short term need?</li>
<li>What      exactly should this person do?</li>
<li>What      skills, knowledge and experience do they need to bring to the table?</li>
</ul>
<p>Answers to these questions depend on many factors, including:</p>
<ul class="unIndentedList">
<li> Budget</li>
<li> Expected growth of the organization</li>
<li> To what extent the BI department wishes to combine business skills with IT skills</li>
<li> Which skills are already available in house</li>
<li> Whether the organization prefers to do all the work in-house or work with external partners</li>
<li> Whether the right person can be hired as an employee or a consultant.</li>
</ul>
<p><strong>The Bottom Line</strong></p>
<p>Successful organizations will require ever more complex information to stay competitive.  As the industry changes and sales reps need to blend more and more sales, medical science and account management skills, we have to integrate data from ever more sources.  While technologies like dashboards make the presentation of information easier, we are still faced with the tricky task of determining which information needs to be available when and to whom.</p>
<p>This article provides some ideas about how to meet these increasing demands without simply doing more work. It is the second in a three-part series of articles looking at <a href="../../../../../2009/02/24/three-steps-to-a-better-bi-future/">Three Steps To A Better BI Future</a>. In the last article we will take a closer look at how to provide the right information to the right people at the right time.</p>
<p>The three articles in this series are:</p>
<ul type="disc">
<li>Step      1: <a href="http://pharma-bi.com/2009/03/03/making-time-for-the-future/">Making Time For The Future</a></li>
<li>Step 2: Looking Ahead &#8211; More      Data, More Details &#8211; Less Work? &#8211; this article</li>
<li><a href="http://pharma-bi.com/2009/08/31/getting-there-the-right-blend-of-people-skills-and-goals/">Step 3: Getting There &#8211; The      Right Blend Of People, Skills And Goals</a></li>
</ul>
]]></content:encoded>
			<wfw:commentRss>http://pharma-bi.com/2009/03/looking-ahead-more-data-more-details-less-work/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Making Time For The Future</title>
		<link>http://pharma-bi.com/2009/03/making-time-for-the-future/</link>
		<comments>http://pharma-bi.com/2009/03/making-time-for-the-future/#comments</comments>
		<pubDate>Tue, 03 Mar 2009 08:45:30 +0000</pubDate>
		<dc:creator>Christine Muser</dc:creator>
				<category><![CDATA[BI Solutions]]></category>
		<category><![CDATA[Marketing]]></category>
		<category><![CDATA[Sales]]></category>

		<guid isPermaLink="false">http://pharma-bi.com/?p=200</guid>
		<description><![CDATA[<p>Time acts like money: we have to invest a little up front to get much more of it down the road.  The initial time investment involves paper, pencil and some brainstorming.  We build on this investment with a little bit of research and use the research results to start building a case for stopping things [...]]]></description>
			<content:encoded><![CDATA[<p>Time acts like money: we have to invest a little up front to get much more of it down the road.  The initial time investment involves paper, pencil and some brainstorming.  We build on this investment with a little bit of research and use the research results to start building a case for stopping things that no longer provide the value they once did.  As we stop doing some things we make time for building a better future.</p>
<p><strong>Paper, Pencil and Brainstorming</strong></p>
<p>Let us start the brainstorming session with a simple question: &#8220;What keeps us busy every day?&#8221; The answer should not be a detailed list of every report the department produces, nor of every research project being conducted.  Rather the goal here is to identify where the big chunks of time are going, yet with enough detail so that we can later group our thoughts in meaningful ways.  Some meaningful groupings might be:</p>
<ul class="unIndentedList">
<li> by department</li>
<li> by brand</li>
<li> by budget line item</li>
<li> by the type of data being used</li>
<li> by cost</li>
<li> by the amount of effort involved.</li>
</ul>
<p>We may want to start with any or all of these bullets to get the brainstorm going.  However, since we are in the process of trying to find TIME for the future, we eventually want to focus on the EFFORT involved.</p>
<p><strong>A Little Bit Of Research</strong></p>
<p>Since perceptions can be deceiving, we need to validate our impressions.  At this stage we need to explore whether individual projects really consume as much time as we think they do.  This is also a good place to ask whether something still is being used or whether it has the same importance it once did.  Some of the more tricky items to review are all the &#8220;favors&#8221; that we inevitably do for others. At this stage of the game we are trying to:</p>
<ul class="unIndentedList">
<li> verify how much effort is required</li>
<li> look for low hanging fruit</li>
<li> search for items that promise big returns.</li>
</ul>
<p>With some projects it will be obvious that they are important and need to get done, yet we can always explore whether they can be done faster and more efficiently.  Options include finding new technology, outsourcing, procuring the co-operation of other departments or hiring someone with more appropriate skills.</p>
<p>For other projects it will be just as obvious that they can be stopped or reduced in size. For everything else, we need the next step.</p>
<p><strong>Building A Case For Stopping Things</strong></p>
<p>Chances are good that eventually we will have picked all the low hanging fruit. Budget constraints, changing business priorities and additional demands may make it necessary to cut back on existing services. And of course, we are still looking to find time for the future!</p>
<p>At this stage we have to weigh the benefits of one project against those of another.  We have to weigh the impact each project has on the company overall and we have to parse perceived need from real need.  Key questions to ask include:</p>
<ul class="unIndentedList">
<li> How does this make you more effective?</li>
<li> How does it help you make better business decisions?</li>
<li> How would it hurt your effectiveness if the information was updated less frequently?</li>
<li> Without this information, how would you get your job done?</li>
</ul>
<p>Notice that these questions do not allow for &#8220;yes&#8221; or &#8220;no&#8221; answers.  They are the starting point for exploring the true value of something that is perceived as a needed service.  Only if we and our information customers explore these questions, can we determine whether other options are available or whether the need is as great as we initially thought.</p>
<p>Building a case takes time and effort &#8211; and if we reach this stage, we should also weigh the needs of our own department and not just the needs of those we support.  To effectively support our information clients we need to also look at how our own service offering needs to evolve to meet changing needs.</p>
<p><strong>Needing Time For The Future</strong></p>
<p>Successful business information managers constantly engage in their own form of R&amp;D, researching and developing solutions that provide timely and accurate information on which to base profitable business decisions.  To meet future demands it is vital that BI managers</p>
<ul class="unIndentedList">
<li> Develop expertise with relevant business issues</li>
<li> Follow market trends</li>
<li> Learn about new data sources</li>
<li> Explore new technologies</li>
</ul>
<p>To be able to do these things, BI managers need to find time in their schedule &#8211; or better yet,  they need to <span style="text-decoration: underline;"><strong>make</strong></span> time for the future.  The tips outlined here should provide a good starting point.</p>
<p>This is the first in a three-part series of articles looking at <a href="../../../../../2009/02/24/three-steps-to-a-better-future/">Three Steps To A Better BI Future</a>.  In the next article we will take a look at how to meet increasing demands without simply doing more work.</p>
<p>The three articles in the series are:</p>
<ul type="disc">
<li>Step      1: Making Time For The Future &#8211; this article</li>
<li><a href="http://pharma-bi.com/2009/03/06/looking-ahead-more-data-more-details-less-work/">Step 2: Looking Ahead &#8211; More      Data, More Details &#8211; Less Work?</a></li>
<li><a href="http://pharma-bi.com/2009/08/31/getting-there-the-right-blend-of-people-skills-and-goals/">Step 3: Getting There &#8211; The      Right Blend Of People, Skills And Goals</a></li>
</ul>
]]></content:encoded>
			<wfw:commentRss>http://pharma-bi.com/2009/03/making-time-for-the-future/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Three Steps To A Better BI Future</title>
		<link>http://pharma-bi.com/2009/02/three-steps-to-a-better-bi-future/</link>
		<comments>http://pharma-bi.com/2009/02/three-steps-to-a-better-bi-future/#comments</comments>
		<pubDate>Tue, 24 Feb 2009 18:58:50 +0000</pubDate>
		<dc:creator>Christine Muser</dc:creator>
				<category><![CDATA[BI Solutions]]></category>
		<category><![CDATA[Marketing]]></category>
		<category><![CDATA[Sales]]></category>

		<guid isPermaLink="false">http://pharma-bi.com/?p=144</guid>
		<description><![CDATA[<p>Managers who provide information to their sales and marketing organizations walk a tight line between drowning in data details and making sure that the information they provide leads to profitable decisions.  The daily fire fights do not leave much time for planning ahead, let alone for envisioning the future.  Yet, all successful managers know that [...]]]></description>
			<content:encoded><![CDATA[<p>Managers who provide information to their sales and marketing organizations walk a tight line between drowning in data details and making sure that the information they provide leads to profitable decisions.  The daily fire fights do not leave much time for planning ahead, let alone for envisioning the future.  Yet, all successful managers know that the future waits for no one &#8211; and that it&#8217;s better to be prepared than to catch up. Thus they periodically make time to determine which activities need to:</p>
<ul>
<li><span style="color: #800000;">Stop</span></li>
<li><span style="color: #ff6600;">Continue</span></li>
<li><span style="color: #008000;">Start</span>.</li>
</ul>
<p>Of course we all know that this traffic light approach to the future sounds more simple than it is to implement.  Implementing &#8220;stop-continue-start&#8221; often requires multiple doses of diplomacy and the stamina and steadfastness of a referee.  Over the course of three articles we will take a look at what it takes to get there.</p>
<p><!--[if gte mso 9]><xml> <w :WordDocument> </w><w :View>Normal</w> <w :Zoom>0</w> <w :PunctuationKerning /> <w :ValidateAgainstSchemas /> <w :SaveIfXMLInvalid>false</w> <w :IgnoreMixedContent>false</w> <w :AlwaysShowPlaceholderText>false</w> <w :Compatibility> <w :BreakWrappedTables /> <w :SnapToGridInCell /> <w :WrapTextWithPunct /> <w :UseAsianBreakRules /> <w :DontGrowAutofit /> </w> <w :BrowserLevel>MicrosoftInternetExplorer4</w>  </xml>< ![endif]--><!--[if gte mso 9]><xml> <w :LatentStyles DefLockedState="false" LatentStyleCount="156"> </w> </xml>< ![endif]--> <!--[if gte mso 10]><br />
<mce :style>< !   /* Style Definitions */  table.MsoNormalTable 	{mso-style-name:"Table Normal"; 	mso-tstyle-rowband-size:0; 	mso-tstyle-colband-size:0; 	mso-style-noshow:yes; 	mso-style-parent:""; 	mso-padding-alt:0in 5.4pt 0in 5.4pt; 	mso-para-margin:0in; 	mso-para-margin-bottom:.0001pt; 	mso-pagination:widow-orphan; 	font-size:10.0pt; 	font-family:"Times New Roman"; 	mso-ansi-language:#0400; 	mso-fareast-language:#0400; 	mso-bidi-language:#0400;} --></p>
<p><!--[endif]--></p>
<p class="MsoNormal">
<ol style="margin-top: 0in;" type="1">
<li class="MsoNormal"><a href="http://pharma-bi.com/2009/03/03/making-time-for-the-future/">Step 1: Making Time For The Future</a></li>
<li class="MsoNormal"><a href="http://pharma-bi.com/2009/03/06/looking-ahead-more-data-more-details-less-work/">Step 2: Looking Ahead &#8211; More Data, More Details &#8211; Less Work?</a></li>
<li class="MsoNormal"><a href="http://pharma-bi.com/2009/08/31/getting-there-the-right-blend-of-people-skills-and-goals/">Step 3: Getting There &#8211; The Right Blend Of People, Skills And Goals</a></li>
</ol>
<p></mce></p>
]]></content:encoded>
			<wfw:commentRss>http://pharma-bi.com/2009/02/three-steps-to-a-better-bi-future/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Multiple Indication Muddle</title>
		<link>http://pharma-bi.com/2009/02/multiple-indication-muddle/</link>
		<comments>http://pharma-bi.com/2009/02/multiple-indication-muddle/#comments</comments>
		<pubDate>Sun, 22 Feb 2009 03:41:17 +0000</pubDate>
		<dc:creator>Christine Muser</dc:creator>
				<category><![CDATA[BI Solutions]]></category>
		<category><![CDATA[Marketing]]></category>

		<guid isPermaLink="false">http://pharma-bi.com/?p=67</guid>
		<description><![CDATA[<p>Pharmaceutical drugs often treat multiple health conditions, and sometimes the dosage varies considerably depending on the patient or the condition being treated. Under these circumstances it becomes necessary to look at how a drug and its competitors are used in real life before one can adequately compare their performance in the market place.</p>
<p>Likewise, comparing products [...]]]></description>
			<content:encoded><![CDATA[<p>Pharmaceutical drugs often treat multiple health conditions, and sometimes the dosage varies considerably depending on the patient or the condition being treated. Under these circumstances it becomes necessary to look at how a drug and its competitors are used in real life before one can adequately compare their performance in the market place.</p>
<p>Likewise, comparing products only by unit volume can significantly distort the market picture and lead to decisions based on incorrect information.  Let us look at a simple, hypothetical example:</p>
<ul>
<li>we have information that 45% of Competitor X&#8217;s volume goes toward treating conditions very different from those that our drug treats &#8211; how should we account for this in our market analysis?</li>
</ul>
<p><strong>Some Factors That Influence Market Calculations</strong></p>
<p>Common sense suggests that we should not calculate market shares based on the total volume of Competitor X, since a large portion of that volume represents non-competing business.  However, we cannot simply deduct 45% of Competitor X&#8217;s volume from the market total.  Why?</p>
<ul>
<li>The market continually evolves, it may be 45% today, but what will it be tomorrow?</li>
<li>A significant portion of Competitor X&#8217;s volume may flow through channels in which we have decided not to compete &#8211; against what volume of Competitor X do we really compete?</li>
<li>A standard course of therapy using Competitor X may require a different number of units than a standard course of therapy using our drug &#8211; how can we tell whether our drug is gaining or loosing market share?</li>
</ul>
<p><strong>We Need A Better Market Definition</strong></p>
<p>We now realize that we need to make some decisions about how to define our market. In other words, we need to develop some rules for turning total product volume into something more useful. In this simple example, we need to take into account</p>
<ul>
<li><strong>how</strong> products are used and</li>
<li><strong>where</strong> they are used.</li>
</ul>
<p>In real life, the factors that need to be considered may be much more complicated.</p>
<p>We also need to gain agreement from business leaders about what these rules should be and what reports will be needed to support their decision making process.  Several discussions will probably be needed, because we have to collect and interpret data that will help us come up with suitable rules.</p>
<p><strong>We Need Appropriate Data</strong></p>
<p>This data may come from a variety of sources, both internal and external to the organization.  Depending on the complexity of the market and the available budget, we may</p>
<ul>
<li>conduct primary research</li>
<li>buy syndicated data</li>
<li>acquire data from other sources like distribution partners or the Federal Government.</li>
</ul>
<p>In this example we may need to look at</p>
<ul>
<li>number of units being used to treat various conditions</li>
<li>product volume in various channels</li>
<li>which conditions are being treated in which channels.</li>
</ul>
<p><strong>We Need Customized Calculations </strong></p>
<p>Using our example, we may have determined the following, also hypothetical, rules</p>
<ul>
<li>Competitor X requires 4 units per course of treatment while our product requires 3 units</li>
<li>We have determined how much to discount Competitor X in each channel</li>
<li>We have chosen to create two market views: a Nation Total and one only for Hospitals</li>
</ul>
<p>Now that we have determined the rules, we have to set up calculations that apply these rules and turn total product volume into something more useful.  But we cannot rest on our laurels &#8211; as the market changes, these rules may need to change &#8212; this means we periodically have to start this process all over again.</p>
<p>To see how this process is used in real life, take a look at one of our <a href="http://pharma-bi.com/case-studies/">Case Studies</a>.</p>
]]></content:encoded>
			<wfw:commentRss>http://pharma-bi.com/2009/02/multiple-indication-muddle/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
